Convergent evolution and targeting of diverse E2 epitopes by human broadly neutralizing antibodies are associated with HCV clearance.
Ogega CO, Skinner NE, Schoenle MV, Wilcox XE, Frumento N, Wright DA, Paul HT, Sinnis-Bourozikas A, Clark KE, Figueroa A, Bjorkman PJ, Ray SC, Flyak AI, Bailey JR.
Ogega CO, et al. Among authors: wright da.
Immunity. 2024 Mar 15:S1074-7613(24)00097-9. doi: 10.1016/j.immuni.2024.03.001. Online ahead of print.
Immunity. 2024.
PMID: 38518779